These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9925977)

  • 1. Super-aspirins in severe angina.
    Harv Heart Lett; 1998 Dec; 9(4):1-3. PubMed ID: 9925977
    [No Abstract]   [Full Text] [Related]  

  • 2. Tirofiban in unstable coronary disease.
    Liron M
    N Engl J Med; 1998 Oct; 339(16):1163-5. PubMed ID: 9776651
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet glycoprotein IIb/IIIa receptor blockade in unstable coronary disease.
    Chesebro JH; Badimon JJ
    N Engl J Med; 1998 May; 338(21):1539-41. PubMed ID: 9593795
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antithrombotic therapy of unstable angina pectoris].
    Lassila R
    Duodecim; 1998; 114(15):1441, 1443-4. PubMed ID: 11552230
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of unstable angina pectoris].
    Luomanmäki K
    Duodecim; 1995; 111(8):715-22. PubMed ID: 8681831
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effective treatment of acute coronary syndromes-IIB or not IIB?
    Klein WW
    Eur Heart J; 1999 Sep; 20(17):1217-9. PubMed ID: 10454971
    [No Abstract]   [Full Text] [Related]  

  • 7. Unstable angina.
    Natarajan M
    Clin Evid; 2002 Jun; (7):214-26. PubMed ID: 12230645
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of glycoprotein IIb/IIIa inhibition on clinical stabilization parameters in patients with unstable angina and non-Q-wave myocardial infarction.
    Okmen E; Cakmak M; Tartan Z; Cam N
    Heart Vessels; 2003 Jul; 18(3):117-22. PubMed ID: 12955426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unstable angina.
    Natarajan M
    Clin Evid; 2002 Dec; (8):225-35. PubMed ID: 12603879
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST-elevation myocardial infarction (PRISM-PLUS Study).
    Huynh T; Theroux P; Snapinn S; Wan Y;
    Am Heart J; 2003 Oct; 146(4):668-73. PubMed ID: 14564321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
    Cannon CP; Weintraub WS; Demopoulos LA; Vicari R; Frey MJ; Lakkis N; Neumann FJ; Robertson DH; DeLucca PT; DiBattiste PM; Gibson CM; Braunwald E;
    N Engl J Med; 2001 Jun; 344(25):1879-87. PubMed ID: 11419424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current point of view on medical treatment of unstable angina].
    Col J
    Arch Mal Coeur Vaiss; 1996 Oct; 89 Spec No 5():15-8. PubMed ID: 8952815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eptifibatide in acute coronary syndromes.
    Segal J
    N Engl J Med; 1999 Jan; 340(1):60; author reply 61. PubMed ID: 9882214
    [No Abstract]   [Full Text] [Related]  

  • 14. Unstable angina: integrating new treatments.
    Schulman SP
    Hosp Pract (1995); 1997 Oct; 32(10):139-42, 144, 146-50. PubMed ID: 9341639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin and antiaggregating therapy in unstable angina.
    Neri Serneri GG; Modesti PA; Abbate R; Gensini GF
    Haemostasis; 1990; 20 Suppl 1():113-21. PubMed ID: 2083863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suboptimal inhibition of platelet aggregation following tirofiban bolus in patients undergoing percutaneous coronary intervention for unstable angina pectoris.
    Soffer D; Moussa I; Karatepe M; Harjai KJ; Boura J; Dixon SR; Grines CL; O'Neill WW; Roubin GS; Moses JW
    Am J Cardiol; 2003 Apr; 91(7):872-5. PubMed ID: 12667576
    [No Abstract]   [Full Text] [Related]  

  • 17. [The new frontier of antithrombotic therapy: ASA + warfarin, the ideal solution?].
    Cimminiello C; Soncini M; Casazza F
    G Ital Cardiol; 1995 Sep; 25(9):1187-93. PubMed ID: 8529856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Fernandez JS; Sadaniantz A
    Med Health R I; 2001 Feb; 84(2):37-43. PubMed ID: 11272658
    [No Abstract]   [Full Text] [Related]  

  • 19. [Platelet membrane glycoproteins as site of pharmacological intervention in the treatment of coronary disease].
    Neumann FJ; Gawaz M; Schömig A
    Dtsch Med Wochenschr; 1997 Oct; 122(40):1224-30. PubMed ID: 9378047
    [No Abstract]   [Full Text] [Related]  

  • 20. GP IIb/IIIa inhibitors: an evidence-based approach to their use.
    Med Manag Netw; 1999 Mar; 7(3):5-9. PubMed ID: 10346546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.